Business Context and Reporting Period
Company: Muscle Maker, Inc. (Note: Metadata listed "Sadot Group Inc." but the filing text identifies the issuer as Muscle Maker, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: July 16, 2019
Reporting Period: Event date July 16, 2019; Compensation covers services from 2017 through 2019.
Context: The Company entered into letter agreements with its non-executive directors to formalize compensation terms and address unpaid services from prior years.
Key Financial Metrics
This filing does not contain standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The financial data provided relates exclusively to director compensation obligations.
- Annual Cash Fee (Future): $9,000 per director.
- Annual Equity Grant (Future): 10,000 shares of common stock per director.
- Committee Service Equity: 1,300 shares per committee (max 2 committees); 1,000 shares for committee chair.
- Retrospective Cash Compensation (2017): Equity valued at $4,500 per director.
- Retrospective Cash Compensation (2018-2019): Equity valued at $9,000 per director (prorated).
Material Changes
Compensation Structure Change: Previously, directors received no compensation. The Company has now established a formal cash and equity compensation structure effective July 16, 2019.
Liability Recognition: The Company has agreed to settle unpaid cash compensation for services rendered in 2017, 2018, and 2019 through the issuance of equity shares priced at the Company's upcoming public offering (Uplisting Offering).
Guidance, Outlook, and Risks
Management Commentary: The Company is transitioning to a formalized director compensation model. Following the public offering, directors will receive cash for the balance of 2019.
Contingencies: The valuation of the retrospective equity awards is contingent upon the price per share of the Company's "Uplisting Offering."
Risks: Dilution of existing shareholders due to the issuance of shares for past and future director services. The filing does not provide specific guidance on future revenue or operational outlook.
Investor Verification Checklist
- Verify the final share price of the "Uplisting Offering" to calculate the exact number of shares issued for retrospective compensation.
- Confirm the total number of shares authorized for issuance to directors to assess potential dilution impact.
- Review the Company's cash position to ensure it can meet the $9,000 annual cash fee obligation for directors post-offering.
- Check for any subsequent filings regarding the completion of the Uplisting Offering.